Skip to main content

This job has expired

You will need to login before you can apply for a job.

Clinical Supply Chain Planner

Employer
Precision BioSciences, Inc.
Location
Durham, NC, United States
Start date
Aug 22, 2020

View more

Discipline
Clinical, Clinical Research, Manufacturing & Production
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Bio NC

Job Details

This role will help further the Pharmaceutical Supply Chain Planning and Forecasting pillar of our Supply Chain organization and report to our Lead Supply Chain Planner. The Clinical Supply Chain Planner will be responsible for planning, ordering and expediting raw materials for our internal manufacturing facility in concert with our manufacturing staff and warehouse associates. Additional responsibilities include setting buffer levels, re-order points and accounting for long lead-times, short expiry and market shortage for all material inputs to manufacturing. This role will facilitate logistical and scheduling functions within the planning sector of the Supply Chain organization. The position will also oversee the day-to-day activities to ensure product/drug product intermediates are delivered to the clinical sites, depots, and manufacturing locations. The Clinical Supply Chain Planner will work with internal and external stakeholders to deliver materials on-time and ready for use in further manufacturing or at the clinical sites. Additionally, this role will aid in forecasting and demand planning for finished drug product and input materials, as well as aid the identification, procurement, and building of any systems that will aid in the planning and buying at manufacturing locations.

Essential Duties and Responsibilities

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position. This list contains the major duties and requirements of the job and is not all-inclusive. Incumbent(s) may be expected to perform role-related duties other than those contained in this document.
  • Support Precision BioSciences supply chain planning function from early clinical stages through commercial launch
  • Track raw materials from time of purchase to time of receipt and assist the receiving location with any incoming receipt issues/discrepancies
  • Identify and communicate any supply delays that may impact manufacturing and/or clinical dosing; proactively resolve/escalate delays
  • Collect supply chain data to enable and refine forecasting
  • Implement logistic and buying strategies
  • Coordinate supply for internal and outsourced activities to ensure timely procurement and distribution of material, including CMO produced drug product intermediates
  • Implement restock and re-order levels for critical inputs; monitor inventory levels to avoid excess inventory, inventory shortages and/or inventory expirations


Qualifications

The requirements listed below are representative of the knowledge, skill, and/or ability required to perform this job successfully.
  • Bachelor's degree in business, engineering or life sciences with a preference for a multi-faceted business-science or engineering background; or equivalent combination of training and experience
  • Minimum of 2 years of experience in operational roles in the Biopharmaceutical industry
  • Skilled in data analytics
  • Strong understanding of Quality Systems & conceptual, strategic & analytical problem solving
  • Excellent communication skills, both verbal and written, and the ability to interface effectively with all level of the organization, as well as with outside contract organizations
  • Working knowledge of cGMP's and pharmaceutical industry procedures and regulations
  • Strong personal alignment with Precision BioSciences values, mission and vision


Travel Requirements
  • No travel is required for this position


Location
  • This is an office-based position located at the main headquarters in downtown Durham, NC and/or manufacturing facility in Research Triangle Park, NC.


Precision BioSciences is dedicated to improving life through its proprietary genome editing platform, ARCUS. Precision BioSciences leverages ARCUS in the development of its product candidates which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision BioSciences is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.

Precision BioSciences provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, disability, genetic information, marital status, amnesty, or status as a covered veteran in accordance with applicable federal, state and local laws. Precision BioSciences complies with applicable state and local laws governing non-discrimination in employment in every location in which the company has facilities. This policy applies to all terms and conditions of employment, including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.

Company

Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing and ex vivo allogeneic CAR T therapies with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly sophisticated edits for gene insertion and/or gene repair. Precision’s in vivo gene editing pipeline consists of wholly-owned preclinical candidates for primary hyperoxaluria type 1 (PBGENE-PH1), familial hypercholesteremia (PBGENE-PCSK9) and chronic hepatitis B (PBGENE-HBV). It has also partnered with Lilly to develop candidates for Duchenne muscular dystrophy and two other programs targeting the liver and CNS. Precision’s allogeneic CAR T pipeline consists of multiple investigational candidates in early-stage clinical trials, including its first and second generation CD19 targeting candidates PBCAR0191 and PBCAR19B for relapsed and/or refractory (R/R) non-Hodgkin and B-cell lymphoma patients. Precision has also prioritized development of PBCAR269A, its BCMA targeted candidate in combination with a gamma secretase inhibitor for R/R patients with multiple myeloma. Precision BioSciences and its in-house manufacturing facility for AAV, mRNA, and CAR T cells is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com

Stock Symbol: DTIL

Stock Exchange: NASDAQ

Company info
Website
Phone
919-314-5512
Location
302 East Pettigrew Street
Durham
North Carolina
27701
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert